「screening」の検索結果

Prepares a DRAFT vendor risk screening brief from the material the user provides on one vendor (questionnaire answers, certificates, assurance reports, policies, contract extracts): per screening topic, what a document evidences with reference, date and scope, what is only asserted, what is missing or contradicted, certificate and report details as stated, and ready-to-send questions for the vendor and the internal owners. No web research, no risk rating, tier, score or recommendation. Use when the user asks to "screen this vendor", "review the vendor's questionnaire answers", "check what the vendor's certificate covers", "what is missing from this due diligence pack" or "draft the follow-up questions for the vendor". Do not use for answering a customer's questionnaire about your own organisation, use vendor-security-questionnaire-prefill instead. Drafts for human review; never approves, authorises or signs off.

日本語の概要は準備中です。原文の説明を表示しています。

輸出入商品の関税分類、通関書類の確認、制裁対象との照合を支援します。米国・EU・英国・アジア太平洋の貿易実務を対象に、関税優遇や税関照会への対応も整理します。

• 商品仕様から関税分類を検討したいとき
• 送り状や原産地証明を確認したいとき
• 自由貿易協定の優遇条件を検討したいとき

Credit risk data cleaning and variable screening pipeline for pre-loan modeling. Use when working with raw credit data that needs quality assessment, missing value analysis, or variable selection before modeling. it covers data loading and formatting, abnormal period filtering, missing rate calculation, high-missing variable removal,low-IV variable filtering, high-PSI variable removal, Null Importance denoising, high-correlation variable removal, and cleaning report generation. Applicable scenarios arecredit risk data cleaning, variable screening, pre-loan modeling preprocessing.

日本語の概要は準備中です。原文の説明を表示しています。

Research Guardian - Ethics Advisory & Bias Detection across all research stages Enhanced VS 3-Phase process: Surface-level screening, deep contextual analysis, constructive recommendations Use when: reviewing research ethics, checking for bias, assessing trustworthiness, QRP screening Triggers: ethics review, IRB, bias detection, QRP, trustworthiness, research integrity, p-hacking, HARKing

日本語の概要は準備中です。原文の説明を表示しています。

Collaboratively build and refine paper screening rubrics through brainstorming, test-driven development, and iterative feedback

日本語の概要は準備中です。原文の説明を表示しています。

NOTE: molecule and target inputs and your NGC_API_KEY are transmitted to external NVIDIA-hosted API endpoints on every call. Use local NIM containers for confidential or proprietary data. Run a complete computational drug discovery pipeline using NVIDIA BioNeMo NIMs: generate drug-like molecules with GenMol, dock them to a protein target with DiffDock, then predict binding affinity with Boltz2. Use this skill whenever the user wants to generate and screen small molecule drug candidates, perform hit discovery, optimize leads against a protein target, or do virtual screening combining molecule generation, docking, and affinity prediction. Triggers on: drug discovery pipeline, hit discovery, lead optimization, virtual screening, molecule generation, molecular docking, binding affinity, GenMol, DiffDock, Boltz2, SMILES, SAFE notation, NIM microservice. This is a multi-step pipeline composing three BioNeMo NIMs.

日本語の概要は準備中です。原文の説明を表示しています。

Screen US stocks for high-quality dividend opportunities combining value characteristics (P/E ratio under 20, P/B ratio under 2), attractive yields (3% or higher), and consistent growth (dividend/revenue/EPS trending up over 3 years). Supports two-stage screening using FINVIZ Elite API for efficient pre-filtering followed by FMP API for detailed analysis. Use when user requests dividend stock screening, income portfolio ideas, or quality value stocks with strong fundamentals.

日本語の概要は準備中です。原文の説明を表示しています。

Builds clear, executable, and auditable inclusion and exclusion criteria for biomedical and clinical research protocols. Always use this skill when a user needs to translate a target population into operational screening rules tied to chart fields, time windows, tests, procedures, prior therapies, exclusions, and reviewable edge cases. Focus on protocol-stage precision, ambiguity reduction, auditability, and screening reproducibility rather than generic study design advice.

日本語の概要は準備中です。原文の説明を表示しています。

Collects candidate biomedical literature across multiple databases, adapts search logic by database, preserves source metadata, and organizes results into a structured, screening-ready candidate pool. Always use this skill when a user wants cross-database literature collection, search strategy construction, candidate paper aggregation, or first-pass evidence organization before deduplication, screening, layered reading, or review planning. Requires real and verifiable literature records only. Every formal literature item must include a real link and DOI when available; never fabricate citations, titles, authors, years, journals, abstracts, PMIDs, or DOIs. If a DOI is unavailable or cannot be verified, state that explicitly rather than inventing one.

日本語の概要は準備中です。原文の説明を表示しています。

Spot a bad client before you sign — the warning signs of the projects that turn into unpaid, scope-creeping nightmares, and how to screen, price, or decline them. Use when asked is this client a red flag, should I take this client, screening a difficult client, or how to avoid bad clients. Produces a read on the warning signs present (haggling, vagueness, disrespect, urgency, unrealistic expectations), what each predicts, screening questions to ask before committing, protective terms if you proceed anyway, and how to decline gracefully — so you avoid the clients who cost more than they pay.

日本語の概要は準備中です。原文の説明を表示しています。

Nominates and assesses CRISPR off-target sites genome-wide. Enumerates candidate sites by mismatch and bulge tolerance with Cas-OFFinder/CRISPRitz, ranks them with the published CFD score (SpCas9-only, relative ranker) or MIT/CRISTA/energy models, runs variant-aware screening against gnomAD/individual genomes (CRISPRme), and frames the empirical genome-wide discovery assays (GUIDE-seq, CIRCLE-seq, CHANGE-seq, DISCOVER-seq, Digenome-seq) and high-fidelity nuclease choice (HiFi Cas9, Sniper-Cas9, eSpCas9, SpCas9-HF1). Use when assessing guide RNA specificity, choosing among candidate guides, screening a therapeutic guide against population variation, or planning empirical off-target validation. Distinguishes predicted vs detected vs validated. On-target activity scoring and deaminase (Cas-independent) base/prime-editor off-targets are separate skills.

日本語の概要は準備中です。原文の説明を表示しています。

Detects and removes contamination in genome assemblies via two disjoint workflows - foreign-sequence screening of a single-organism (eukaryote/isolate) assembly with NCBI FCS-GX (GenBank-submission-mandatory), FCS-adaptor, and BlobToolKit blob plots; and MAG/bin quality assessment with CheckM2 plus GUNC (chimerism) plus GTDB-Tk taxonomy, judged against MIMAG. Covers why CheckM2 alone is blind to disjoint-marker chimeras, the FCS-GX RAM wall, organelle/NUMT triage, strain heterogeneity, and the HGT-vs-contamination (tardigrade) trap. Use when screening an assembly for foreign contamination before GenBank submission, assessing MAG completeness/contamination/chimerism, deciding which contigs to remove, or distinguishing real HGT from contaminant contigs.

日本語の概要は準備中です。原文の説明を表示しています。

Screen a client, counterparty, payer or corporate against the sanctions lists published by the designating authorities themselves — the UK Sanctions List (FCDO), OFSI, the UN Security Council, the EU consolidated list and OFAC's SDN and non-SDN lists. Use when onboarding, before taking a payment, before completing a transaction, or whenever a name must be checked against sanctions. Produces candidates and provenance, never a clearance: the record names every list searched with its publication date and count, states what was NOT searched, and ends at a blank decision block. Fails closed — a cache that is missing, damaged, truncated or stale is reported NOT SEARCHED and the process exits non-zero, so nothing can read an incomplete run as clean. Matches across transliteration, diacritics, homoglyphs and initials, because nobody spells a name the way the publisher does. Standard library only; screening opens no network connection.

日本語の概要は準備中です。原文の説明を表示しています。

Sanctions and export control analysis tool for Claude Desktop. Real-time individual screening across 30+ official lists (UN, EU, OFAC, OFSI, French DGT...), sectoral analysis, dual-use goods (EU Reg. 2021/821), US/China extraterritorial regimes (EAR, ITAR, FDPR, ECL), USD/SWIFT risk and jurisdictional mapping across 30+ countries. All results sourced and verified in real time — no memory-based answers. Responds in French, English, German, Spanish, Russian and Chinese. Updated 19 May 2026 (EU 20th package, UK SEUC, Cuba EO). Indicative guidance only — not legal advice.

日本語の概要は準備中です。原文の説明を表示しています。

AiZynthFinder retrosynthetic route planning (CASP) from AstraZeneca Molecular AI. Monte Carlo tree search guided by a template-based neural expansion policy recursively disconnects a target SMILES until precursors are found in a purchasable stock. Covers config.yml (v4 format), aizynthcli batch screening, the AiZynthFinder/AiZynthExpander Python API, one-step disconnections, custom stocks via smiles2stock, scorers, Retro*/breadth-first/DFPN search alternatives, and reading output.json.gz / trees.json. Use for synthesis route planning, synthesizability screening, and building-block/precursor search. For reaction barriers use neb-irc-activation-energy; for 2D reaction scheme drawing use rdkit-chemdraw-cdxml.

日本語の概要は準備中です。原文の説明を表示しています。

Screen US stocks for high-quality dividend opportunities combining value characteristics (P/E ratio under 20, P/B ratio under 2), attractive yields (3% or higher), and consistent growth (dividend/revenue/EPS trending up over 3 years). Supports two-stage screening using FINVIZ Elite API for efficient pre-filtering followed by FMP API for detailed analysis. Use when user requests dividend stock screening, income portfolio ideas, or quality value stocks with strong fundamentals.

日本語の概要は準備中です。原文の説明を表示しています。

Quantitative stock screening, forward-looking valuation outlier detection, backward-looking financial statement validation, PEG ratio analysis, earnings growth profile assessment, turnaround vs value trap discrimination, data mining bias prevention

日本語の概要は準備中です。原文の説明を表示しています。

Screen job applications against requirements and score candidates objectively. Use when a user asks to review applications, evaluate candidates, screen resumes, rank applicants, assess qualifications against a job description, shortlist candidates, or build a hiring scorecard.

日本語の概要は準備中です。原文の説明を表示しています。

健身私教 — 为客户设计、指导和推进个性化训练方案的专业工艺, 有别于团课教练、物理治疗师或运动队教练: (a) 训练方案设计与周期化 (线性 / 波动 / 板块周期化 Bompa & Haff; NSCA《力量训练与体能训练精要》行业圣经; Schoenfeld 肌肥大机制; Helms/Valdez/Morgan 肌肉与力量金字塔; 共轭训练法 Simmons/Westside; Starting Strength 线性渐进 Rippetoe; Renaissance Periodization 训练量地标 Israetel); (b) 动作评估与筛查 (FMS 功能性动作筛查 Gray Cook; NASM CEx 纠正性训练连续体 抑制-拉伸-激活-整合; 关节逐级方法 Cook/Boyle; 姿势与代偿模式识别; PAR-Q+ 与 ACSM 运动前筛查指南); (c) 教学与指令 (外部 vs 内部注意焦点 Wulf; 差异化学习 Schöllhorn; 约束导向方法 Davids/Renshaw; RIR/RPE 自动调节 Zourdos/Helms; 动机访谈在健身中的应用 Rollnick/Miller); (d) 营养指导的执业边界 (宏量营养素周期化; Precision Nutrition / ISSN 立场声明的循证建议; 边界: 私教提供一般性指导, 医学营养治疗需 RD/RDN 资质; 能量可用性与 RED-S Mountjoy IOC 共识); (e) 商业与客户管理 (客户留存与方案依从; 咨询与销售伦理; 线上教练平台与规模化 Goodman PTDC; 方案交付工具 TrueCoach/Trainerize/TrainHeroic; 课时定价模型; 独立教练 vs 健身房雇员); (f) 专项方向 (运动表现 CSCS; 纠正性训练 CES; 老年健身 SFN; 产前产后; 青少年 YSCA; 适应性 / 无障碍健身; 健美 / 形体; 力量举; 耐力运动 S&C)。诚实处理: 兄弟科学 vs 循证之争, 补剂行业利益冲突, 合成代谢激素使用现状 (诚实但不推广: 匿名调查约 30% 有经验男性健身者使用过 — 业内估, Kanayama/Pope/Hudson 记录健康风险, WADA 禁用清单用于竞技语境), 体型焦虑与进食障碍风险 (男性私教肌肉变形症, 正食症倾向, NEDA 负责任语言指南), 健身房掠夺性销售 (高压推销、误导性对比照、长约锁定), 执业边界违规 (私教诊断伤病或超范围开饮食处方), 线上教练认证造假 (周末速成、未经认可的认证)。不含: 物理治疗 / 康复治疗 (持照医疗职业), 不含: 团课教练 (Les Mills/Zumba/CrossFit 分馆教练 — 相邻但不同), 不含: 精英竞技运动教练 (团队项目周期化, 不同职业路径), 不含: 营养作为主业 (临床营养学需单独资质)。 (Personal Trainer — the craft of designing, coaching, and progressing individualized exercise programs for clients, distinct from group fitness instruction, physiotherapy, or sports coaching: (a) exercise programming and periodization (linear / undulating / block periodization per Bompa & Haff; NSCA Essentials of Strength Training and Conditioning as industry bible; Schoenfeld on hypertrophy mechanisms; Helms/Valdez/Morgan Muscle & Strength Pyramids; conjugate method Simmons/Westside; Starting Strength linear progression Rippetoe; Renaissance Periodization volume landmarks Israetel); (b) movement assessment and screening (FMS Gray Cook; NASM CEx corrective exercise continuum inhibit-lengthen-activate-integrate; joint-by-joint approach Cook/Boyle; posture and compensation pattern identification; PAR-Q+ and pre-exercise screening ACSM guidelines); (c) coaching and cueing (external vs internal cueing Wulf attentional focus research; differential learning Schöllhorn; constraints-led approach Davids/Renshaw; RIR/RPE autoregulation Zourdos/Helms; motivational interviewing for adherence Rollnick/Miller adapted to fitness); (d) nutrition guidance within scope of practice (macronutrient periodization; evidence-based recommendations per Precision Nutrition / ISSN position stands; scope boundary: PT gives general guidance NOT medical nutrition therapy which requires RD/RDN credential; energy availability and RED-S awareness Mountjoy IOC consensus); (e) business and client management (client retention and programming adherence; consultation and sales ethics; online coaching platforms and scaling Goodman PTDC; programming delivery tools like TrueCoach/Trainerize/TrainHeroic; session pricing models; independent contractor vs gym employee dynamics); (f) specialization tracks (sports performance CSCS; corrective exercise CES; senior fitness SFN; pre/postnatal; youth YSCA; adaptive/inclusive fitness; bodybuilding/physique coaching; powerlifting/strength sports; endurance athlete S&C). Evidence-based practice as the core ethos: Schoenfeld/Krieger meta-analyses on volume-response, Helms systematic reviews on protein/resistance training, Brad Schoenfeld's MASS journal bridging research to practice, Menno Henselmans and Eric Helms as practitioner-researchers, Greg Nuckols Stronger By Science as translation layer. Chinese fitness industry context: rapid growth of personal training in commercial gyms (Keep/Lefit/Megafit chains), NSCA-CPT and ACE-CPT as dominant certifications alongside local CSFA (China Sport and Fitness Association) credential, '体适能' (physical fitness) as formal term, online coaching boom post-COVID, PT business models in tier 1-3 cities diverge sharply. Honest treatment of: bro science vs evidence-based d

日本語の概要は準備中です。原文の説明を表示しています。

Check product images against a database of policy-violating items using visual similarity matching. Triggered when users mention policy compliance check, product image compliance review, violation detection, prohibited product screening, image-based compliance audit, pre-listing risk screening, or product image risk check. Even if the user does not explicitly say "compliance," this skill should be triggered whenever the need involves comparing product images against a violation database.

日本語の概要は準備中です。原文の説明を表示しています。

Text trademark detection and infringement risk analysis for e-commerce product listings. Trigger when users mention trademark detection, trademark risk check, brand infringement screening, product title trademark scan, text trademark search, listing compliance check, intellectual property risk assessment, text trademark detection, trademark infringement, brand infringement screening, listing compliance, intellectual property risk, Ruiguan. Even if the user does not explicitly say "trademark", trigger this skill whenever their need involves checking whether product text (titles, descriptions, bullet points) contains potentially infringing trademarks.

日本語の概要は準備中です。原文の説明を表示しています。

Use Nexscope data to search and filter Amazon products, supporting multi-dimensional criteria including price, monthly sales, BSR ranking, gross margin, ratings, fulfillment method, badges, seller origin, and more across multiple Amazon marketplaces. Trigger when the user mentions Amazon product selection research, product filtering, sales filtering, product discovery, BSR analysis, niche product discovery, competitor analysis, market opportunity assessment, product-level market size estimation, gross margin screening, Nexscope product selection, Amazon product selection, sales filtering, BSR analysis, profit screening, market analysis, product selection tool. Even if the user does not explicitly mention "Nexscope", if their need involves filtering and analyzing Amazon product-level data for product selection, this skill should also be triggered.

日本語の概要は準備中です。原文の説明を表示しています。

Amazon product discovery and potential bestseller mining via Nexscope data. Triggered when users mention product mining, potential bestsellers, high-conversion product selection, click growth analysis, market growth opportunities, keyword-based product selection, FBA profit screening, niche market product discovery, seller origin filtering, Nexscope data, FBA profitability screening, keyword-based product selection. Even if users do not explicitly mention "Nexscope", this skill should be triggered whenever the task involves keyword-driven Amazon product selection based on conversion rates, click volume, and profitability metrics.

日本語の概要は準備中です。原文の説明を表示しています。

🇺🇸 User Interview & Cold-Start Operations Playbook — Battle-tested framework from HeyGen's 937 interviews to PMF. Complete SOP for user screening, interview execution, Beta testing methodology, cold-start user operations, churn analysis, and user grading systems. 🇨🇳 用户访谈与冷启动运营实战手册 — 基于 HeyGen 937 场访谈验证的 PMF 方法论。包含用户筛选、访谈执行、Beta 测试设计、冷启动用户运营、流失分析、用户分级体系完整 SOP。 🇯🇵 ユーザーインタビュー＆コールドスタート運営プレイブック — HeyGenの937回インタビューで検証されたPMF方法論。ユーザースクリーニング、インタビュー実行、Betaテスト設計、コールドスタートユーザー運営、離脱分析、ユーザーグレーディング。 🇰🇷 사용자 인터뷰 & 콜드 스타트 운영 플레이북 — HeyGen 937회 인터뷰로 검증된 PMF 방법론. 사용자 스크리닝, 인터뷰 실행, Beta 테스트 설계, 콜드 스타트 사용자 운영, 이탈 분석, 사용자 등급 시스템. Triggers: "user interview" | "user research" | "customer discovery" | "PMF" | "product-market fit" | "beta test" | "beta testing" | "cold start users" | "cold start operations" | "churn analysis" | "user grading" | "用户访谈" | "用户调研" | "冷启动" | "冷启动运营" | "Beta测试" | "流失分析" | "用户分级"